In this issue:
Joint replacement surgery rates in NZ
An analysis of healthcare use among RA patients
Very low-dose GCs safe in early active RA
A protective effect between OCs and ACPA-positive RA
How hip/knee OA relates to difficulty walking
PsA therapy often needs to be adjusted for residual disease
‘Real world’ data on responses to initial MTX doses
MRI targets: inappropriate outcomes for T2T escalation
Optimising AAV maintenance treatment
Tapering vs steady-state MTX + TCZ for RA
Please login below to download this issue (PDF)